Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute pseudomonas aeruginosa pneumonia

Chest

Volumn 122, Issue 6, 2002, Pages 2127-2136

  Dukelow, Adam M ^a   Weicker, Sean ^b   Karachi, Tim A ^b   Razavi, Habib M ^b   McCormack, David G ^b   Joseph, Mariamma G ^b   Mehta, Sanjay ^b,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Respirology Division   (Canada)

Author keywords

Exhaled nitric oxide; Inhaled nitric oxide; Lung inflammation; Nitric oxide; Nitric oxide donors; Nitrites nitrates

Indexed keywords

ANTIINFLAMMATORY AGENT; DIETHYLENETETRAAMINE NONOATE; NITRATE; NITRITE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BLOOD LEVEL; CELL INFILTRATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; ENDOTRACHEAL INTUBATION; EXHALATION; IN VITRO STUDY; LEUKOCYTE; LUNG ALVEOLUS CELL; MALE; MEDICAL ASSESSMENT; MOUSE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0036928675     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6.2127     Document Type: Article

References (38)

1. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-892
2. Baughman RP, Tapson V, McIvor A. The diagnosis and treatment challenges in nosocomial pneumonia. Diagn Microbiol Infect Dis 1999; 33:131-139
3. Fang FC. Perspectives series: Host/pathogen interactions; mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818-2825
4. Singh S, Wort SJ, Evans TW. Inducible nitric oxide and pulmonary infection. Thorax 1999; 54:959-960
5. Webert KE, Vanderzwan J, Duggan M, et al. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Crit Care Med 2000; 28:2397-2405
6. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-1174
7. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
8. Steudel W, Hurford WE, Zapol WM. Inhaled nitric oxide: Basic biology and clinical applications. Anesthesiology 1999; 91:1090-1121
9. Ekekezie II, Thibeault DW, Zwick DL, et al. Independent and combined effects of prolonged inhaled nitric oxide and oxygen on lung inflammation in newborn piglets. Biol Neonate 2000;77:37-44
10. Sato Y, Walley KR, Klut ME, et al. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999; 159:1469-1476
11. Dahm PL, Blomquist S, De Robertis E, et al. Effects of NO inhalation on pulmonary leukocyte sequestration and blood volume in porcine endotoxaemia. Intensive Care Med 2000; 26:336-343
12. Phillips ML, Hall TA, Sekar K, et al. Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients. Pediatrics 1999; 104:1095-1100
13. Francoeur M, Troncy E, Blaise G. Inhaled nitric oxide: Technical aspects of administration and monitoring. Crit Care Med 1998; 26:782-796
14. Maragos CM, Morley D, Wink DA, et al. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: Vasorelaxant effects. J Med Chem 1991; 34:3242-3247
15. Diodati JG, Quyyumi AA, Keefer LK. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effect in the rabbit. J Cardiovasc Pharmacol 1993; 22:287-292
16. Hirasaki A, Jones KA, Perkins WJ, et al. Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: Effects on airway smooth muscle. J Pharmacol Exp Ther 1996; 278:1269-1275
17. Keefer LK, Nims RW, Davies KM, et al. NONOates as nitric oxide donors: Convenient nitric oxide dosage forms. Methods Enzymol 1996; 268:281-293
18. Vanderzwan J, McCaig L, Mehta S, et al. Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia. Eur Respir J 1998; 12:1388-1396
19. Hrabie JA, Klosie JR, Wink DA. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 1993; 8:1472-1476
20. Weicker S, Karachi TA, Scott JA, et al. Non-invasive measurement of exhaled nitric oxide in a spontaneously breathing mouse. Am J Respir Crit Care Med 2001; 163:1113-1116
21. Hess D, Bigatello L, Hurford WE. Toxicity and complications of inhaled nitric oxide. Respir Care Clin N Am 1997; 3:487-503
22. Kiff RJ, Moss DW, Moncada S. Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: Implications for inhalation therapy. Br J Pharmacol 1994; 113:496-498
23. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airway. Am J Respir Crit Care Med 1994; 149:538-551
24. Ramamurthi A, Lewis RS. Measurement and modeling of nitric oxide release rates for nitric oxide donors. Chem Res Toxicol 1997; 10:408-413
25. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993; 22:S3-S9
26. Grisham MB, Jourd'heuil D, Wink DA. Nitric oxide: I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am J Physiol 1999; 39:G315-G321
27. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87:1620-1624
28. Yoshida K, Kasama K. Biotransformation of nitric oxide. Environ Health Perspect 1987; 73:201-205
29. Vanderford PA, Wong J, Chang R, et al. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. J Cardiovasc Pharmacol 1994; 23:113-119
30. Morley D, Maragos CM, Zhang XY, et al. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 1993; 21:670-676
31. Brilli RJ, Krafte-Jacobs B, Smith DJ, et al. Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J Appl Physiol 1997; 83:1968-1975
32. Hampl V, Tristanifirouzi M, Hutsell TC, et al. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res 1996; 31:55-62
33. Jacobs BR, Brilli RJ, Ballard ET, et al. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am J Respir Crit Care Med 1998; 158:1536-1542
34. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391:393-397
35. Tavafmotamen H, Miner TJ, Starnes BW, et al. Nitric oxide mediates acute lung injury by modulation of inflammation. J Surg Res 1998; 78:137-142
36. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [erratum appears in Cell 1995; 81:1170]. Cell 1995; 81:641-650
37. Zhu S, Ware LB, Geiser T, et al. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163:166-172
38. Zhu S, Kachel DL, Martin WJ, et al. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol 1998; 19:L1031-L1039